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MonocrotalineOur objective was to investigate the role of creatine kinase in the contractile dysfunction of right ventricular failure
caused by pulmonary artery hypertension. Pulmonary artery hypertension and right ventricular failure were in-
duced in rats by monocrotaline and compared to saline-injected control animals. In vivo right ventricular diastolic
pressure–volume relationships were measured in anesthetized animals; diastolic force–length relationships in sin-
gle enzymatically dissociatedmyocytes andmyocardial creatine kinase levels byWestern blot.We observed diastol-
ic dysfunction in right ventricular failure indicated by signiﬁcantly steeper diastolic pressure–volume relationships
in vivo and diastolic force–length relationships in single myocytes. There was a signiﬁcant reduction in creatine ki-
nase protein expression in failing right ventricle. Dysfunction alsomanifested as a shorter diastolic sarcomere length
in failingmyocytes. This was associatedwith a Ca2+-independentmechanism that was sensitive to cross-bridge cy-
cling inhibition. In saponin-skinned failingmyocytes, addition of exogenous creatine kinase signiﬁcantly lengthened
sarcomeres, while in intact healthy myocytes, inhibition of creatine kinase signiﬁcantly shortened sarcomeres. Cre-
atine kinase inhibition also changed the relatively ﬂat contraction amplitude–stimulation frequency relationship of
healthy myocytes into a steeply negative, failing phenotype. Decreased creatine kinase expression leads to diastolic
dysfunction. We propose that this is via local reduction in ATP:ADP ratio and thus to Ca2+-independent force pro-
duction and diastolic sarcomere shortening. Creatine kinase inhibition also mimics a deﬁnitive characteristic of
heart failure, the inability to respond to increased demand. Novel therapies for pulmonary artery hypertension
are needed. Our data suggest that cardiac energetics would be a potential ventricular therapeutic target.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Impaired systolic and/or diastolic function and a decreased ability to
respond to increased demand are characteristics of the failingmyocardi-
um [1]. In tandem with these functional deﬁcits are metabolic changes
that result in compromised energy supply which may underlie the im-
paired function [2,3].
Creatine kinase (CK) buffers locally accumulated ADP and provides a
feedback to mitochondrial respiration. It has been demonstrated, in
humans with left ventricular (LV) hypertrophy, that total CK activity is
decreased [4] and that CK ﬂux is a predictor of mortality in heart failure
patients [5]. At the level of the sarcomere, the myocardial contractile
unit, binding of CK to the M-line has been shown to be important inBiomedical Sciences, University
. This is an open access article undermaintaining normal ATP:ADP ratio, whereas depletion or inhibition of
CK can lead to a local decrease in [ATP] and build-up of ADP; conditions
that can favor Ca2+-independent force generation [6,7].
The role of metabolic dysfunction in right ventricular (RV) failure
caused by pulmonary artery hypertension (PAH) is less well studied
than in left ventricular (LV) failure. Treatment of PAH is focused on
the pulmonary vasculature, however, hypertension increases afterload
on the RV and results in RV hypertrophy and failure. Right heart failure
is the most common cause of death in patients with PAH [8,9]. There is
currently no cure for PAH and an acknowledged need for novel ap-
proaches to treatment and cure [9,10]. In this context we aimed to
study the possible link between CK and contractile dysfunction in a
well-established animal model of PAH and RV failure.
2. Materials and methods
For detailed methods see Supplementary data.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Animal and organ weights. Final day parameters for saline treated (CON) and 60 mg/kg
MCT (FAIL) animals. Right ventricular free wall (RV), left ventricular free wall (LV).
*P b 0.05, ***P b 0.001 vs CON.
CON (N = 38) FAIL (N = 43)
Body weight (g) 323 ± 3.4 267 ± 3.6***
Heart weight (g) 1.20 ± 0.02 1.42 ± 0.04***
RV weight (g) 0.24 ± 0.01 0.38 ± 0.02***
LV weight (g) 0.58 ± 0.02 0.52 ± 0.02*
Lung weight (g) 1.87 ± 0.11 2.56 ± 0.09***
Liver weight (g) 12.85 ± 0.22 10.82 ± 0.29***
Heart weight/body weight (mg/g) 3.64 ± 0.13 5.33 ± 0.14***
RV weight/LV weight (mg/mg) 0.42 ± 0.02 0.77 ± 0.04***
Lung weight/body weight (mg/g) 5.63 ± 0.34 9.66 ± 0.37***
Liver weight/body weight (mg/g) 38.8 ± 1.24 40.28 ± 0.74
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Male Wistar rats (200 g) received a single intraperitoneal injection
of 60 mg/kg MCT to induce RV failure (FAIL) or an equivalent volume
of saline as control (CON). Rats were killed upon showing external clin-
ical signs of heart failure as previously reported (e.g. [11–15]). These
were weight loss of at least 10 g on consecutive days, dyspnea, cold ex-
tremities and lethargy (median time 23 days, range 18–26 days) or on
equivalent days for CON animals. Experiments were conducted in ac-
cordwithHealth Research Extension Act (public law99–158, 1985 “An-
imals in Research”) and with the Directive 2010/63/EU of the European
Parliament UK Home Ofﬁce regulations and local ethical approval.
2.2. In vivo hemodynamics
In vivo hemodynamic measurements were made in mechanically
ventilated rats, anesthetized with 1.5% isoﬂurane mixed with O2. The
chest was opened and a Millar conductance catheter passed through
the RV free wall into the RV cavity to simultaneously measure pressure
and volume. Pressure–volume (PV) loops were recorded and the slope
of the end-diastolic pressure–volume relationship (EDPVR) measured
by occlusion of the ascending vena cava. In isolated hearts, collagen
was assessed by picrosirius red staining of 10 μm thick cryosections
cut through the ventricular short axis. Staining was measured by a
blinded researcher using ImageJ (National Institute of Health, Bethesda,
USA).
2.3. Single myocyte studies
Singlemyocyteswere isolated and intracellular Ca2+ ([Ca2+]i)mon-
itored using the ratiometric Ca2+ dye fura-2-AM (Invitrogen, Paisley,
UK) as previously described [16]. Simultaneous recordings of sarcomere
length (SL) and fura-2 signal were acquired using Ion Wizard software
(IonOptix, Milton, USA). Myocytes were ﬁeld stimulated via external
platinum electrodes at the desired frequency. Unless otherwise stated,
experiments were carried out at 37 °C. The method of Hongo et al.
[17] was used to measure myoﬁlament Ca2+ sensitivity in intact
myocytes.
To investigate the control of resting SL, Tyrode solution was modi-
ﬁed by inclusion of the intracellular Ca2+ buffer BAPTA-AM (100 μM)
or BAPTA-AM plus the myosin ATP-ase and cross-bridge cycling inhibi-
tor 2,3-butanedione monoxime (BDM; 40 mM, Sigma). To inhibit all
forms of CK, the irreversible agent 2, 4-dinitro-1-ﬂuorobenzene
(DNFB; 20 μM, Sigma) was added for 10 min. To test the role of CK in
controlling resting SL, myocytes were permeabiliized with saponin
(0.01 mg/ml) in an intracellular-like solution. Cells were incubated in
this solution with or without exogenous muscle isoform CK-(MM)
from bovine heart muscle (Sigma) at a concentration of 4.4 mg/ml
(total activity 250 U/ml) for 30min before SLwasmeasured at 20–23 °C.
Mechanical manipulation of myocytes was performed with a
MyoStretcher (IonOptix, Milton, USA). Myocytes were attached to stiff
glassﬁbers usingMyoTak™ glue (IonOptix) [18,19]. Cellswere stretched
between 2.5 and 10 μmwhile isometric force transients were recorded
and the end diastolic force–length relationship (EDFLR), the cellular
equivalent of the in vivo EDPVR, was measured [19].
2.4. Western blot analysis of creatine kinase
Muscle CK protein (CK-M) levels fromRVand LV tissue isolated from
CON and FAIL animals were assessed by bicinchoninic acid assay and
Western blotting with primary antibodies for CK-M ((MM-2) sc-
69848, 1:500, Santa Cruz Biotech and anti-GAPDH, G9545, 1:100,000,
Sigma). For mitochondrial-CK (CK-mito). the primary antibody was
(sMt CK (c-18): sc15168 at 1:200 dilution, Santa Cruz) and secondary
antibody Donkey anti-Goat HRP (Stratech 705-035-147) at 1:5000 dilu-
tion. Brain-CK (CK-B) was assessed with (CK-B (G-6): sc-374072antibody, Santa Cruz). GAPDHwas used as a loading control for protein
normalization. Signals were quantiﬁed using Aida Image Analyzer
(v4.22) and normalized to GAPDH.
2.5. Statistics
Results are presented as mean ± SEM. P b 0.05 was considered sig-
niﬁcant. Unpaired t-tests, one-way or two-way repeated measures
ANOVA with multiple testing corrections were used as appropriate.
Numbers of rats, hearts and myocytes used in each experiment are
given in the relevant table and ﬁgure legends.
3. Results
3.1. Diastolic dysfunction in vivo
Consistent with previous reports, there was a signiﬁcant increase in
the heart: body weight and lung: bodyweight ratio in FAIL animals. The
increase in heart weight was principally due to a signiﬁcant increase in
the RV: LV weight, indicating RV hypertrophy (Table 1).
In vivo measurement of RV pressure and volume showed a sig-
niﬁcant increase in systolic pressure (see Suppl. Table 1). PV loops
(Fig. 1A) were used to calculate EDPVR which were signiﬁcantly in-
creased in FAIL hearts (Fig. 1B) suggesting diastolic dysfunction in the
form of increased resistance to ﬁlling. Increased ﬁbrosis could be a
cause of diastolic dysfunction, however histological measurement of ﬁ-
brosis revealed no signiﬁcant differences between CON and FAIL hearts
(Fig. 2).
3.2. Diastolic dysfunction in stretched single cardiac myocytes
The source of dysfunction might therefore originate within the
myocytes. Indeed when single cardiac myocytes were attached to
glass ﬁbers and stretched (Fig. 3A, B) the resultant slope of the EDFLR
(the cellular equivalent of the in vivoEDPVR)was signiﬁcantly increased
in RV FAIL myocytes (Fig. 3C). For consistency with previous reports,
data are presented as the absolute change in force per unit distance
[19]. Although FAIL myocytes tended to have a larger cross-sectional
area (XSA) (RV FAIL 551 ± 60 μm2, RV CON 375 ± 29 μm2, P = 0.06),
resting force normalized to XSA and % length change was still sig-
niﬁcantly greater in FAIL myocytes (CON 0.07 ± 0.01, FAIL 0.13 ±
0.03 mN·mm−2. %−1 length change, P b 0.05) indicating that larger
XSA was not the sole cause of the steeper EDFLR in FAIL myocytes.
Resting SL of RVmyocytes from FAIL hearts was signiﬁcantly shorter
than either LV myocytes from FAIL or RV myocytes from CON hearts
(Fig. 4A). This shorter SL was not caused by raised diastolic [Ca2+]i
(fura-2 340:380 ratio was not different between groups, Fig. 4B).
When intact myocytes re-lengthened following tetanization (Fig. 5A)
the slope of the SL-fura-2 340:380 ratio was shallower in FAIL than
CONmyocytes (Fig. 5B). This slope is an index ofmyoﬁlament Ca2+ sen-
sitivity, with a steeper slope indicating increased Ca2+ sensitivity. The
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Fig. 1.Measurement of EDPVR relationships. Final day in vivo RV hemodynamicmeasurements. A. Examples PV loops in CON and FAIL heart, lines indicate end diastolic pressure volume
relationships (EDPVR) and end systolic pressure volume relationships. B. Mean EDPVR relationships. FAIL rats displayed signiﬁcantly steeper EDPVR. N = 7 CON and 8 FAIL hearts.
*P b 0.05.
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RV FAIL myocytes was not caused by intrinsic highermyoﬁlament Ca2+
sensitivity.
3.3. Ca2+-independent shortening of diastolic sarcomere length in failing
myocytes
To investigate a possible Ca2+-independent source of diastolic SL
shortening in RV FAIL myocytes, resting SL was ﬁrst measured in
Tyrode's solution. When the same cells were exposed to the intracel-
lular Ca2+ buffer BAPTA-AM (100 μM) SL increased and increased fur-
ther upon additional exposure to the myosin ATP-ase inhibitor BDM
(40 mM) (Fig. 6A). The Ca2+-dependent changes in SL (caused by
BAPTA alone) were compared to the Ca2+-independent change in SL
(additional increase in SL caused by BDM). The Ca2+-independent
change in SL was signiﬁcantly greater in FAIL myocytes compared to
both the Ca2+-independent change in SL in CON and to the Ca2+-
dependent change in SL in FAIL (Fig. 6B).
3.4. Creatine kinase expression and diastolic sarcomere length
Expression of CK-M was signiﬁcantly reduced in RV FAIL (Fig. 7A)
but not different between any LV groups (Fig. 7B). There was also aCON
FAIL
RV LV
100 µm
A
Fig. 2.Measurement of collagen in CON and FAIL hearts. A. Example images of RV and LV secti
(red), the threshold value was optimized for each section and applied to both RV and LV. B. Th
was not increased at this stage of MCT-induced heart failure. N = 7 CON and 7 FAIL hearts.signiﬁcant reduction in CK-mito in RV FAIL (Fig. 7C). We were unable
to detect expression of CK-B in either CON or FAIL samples.
In the presence of 10 mM phosphocreatine, SL was signiﬁcantly
shorter in skinned RV FAIL myocytes than RV CON (as seen in intact
cells). Exposure to 4.4 mg/ml exogenous CK caused no change in SL in
CON cells but signiﬁcantly increased SL in RV FAIL cells such that their
SL was no longer signiﬁcantly shorter than CON cells (Fig. 7D). This ef-
fect was dependent upon the presence of the substrate PCr because, ex-
ogenous CK-M did not lengthen SL in the absence of PCr (Suppl. Fig. 1).
Resting SL was not different between the groups of LV myocytes and
adding CK did not alter SL (Fig. 7E). The observations in Fig. 7 demon-
strate a reversible link between CK levels and resting SL.
When intact cells were exposed to the CK inhibitor DNFB (20 μM)
there was a signiﬁcant shortening of SL in all cells (Fig. 8A) however
the greatest effects were in LV cells and RV cells from CON hearts,
that is, the cells with the highest levels of CK (see Fig. 7). Signiﬁcantly
shorter SL was also observed in permeabilized RV CON (− DNFB
1.94±0.02 μm,+DNFB 1.88±0.02 μm, P b 0.05) and LVCONmyocytes
(−DNFB 1.93±0.01 μm,+DNFB 1.88±0.01 μm, P b 0.001) exposed to
DNFB, N = 10 myocytes in each group from 1 heart.
A systolic characteristic of RV FAIL cells is a steeply negative contrac-
tion–stimulation frequency relationship compared to CON cells [14]
(Fig. 8B). CON myocytes exposed to DNFB displayed a steeply negative
contraction–frequency relationship similar to FAIL myocytes (Fig. 8B).B
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Fig. 3. Diastolic force–length relationships in single RV CON and FAIL myocytes. A. Images of a single RVmyocyte attached to glass ﬁbers before and after a stretch that increased SL from
1.83 to 1.93 μm. B. Example of stepwise increases in cell length changes (top) separated by a return to resting length imposed on a CON cell and the corresponding change in force (bottom)
during isometric contraction and relaxation. C. The difference in diastolic force between resting length and each stretch (ΔFdiastolic) was used to construct an end-diastolic force–length
relationship (EDFLR). The slope of the EDFLR was signiﬁcantly steeper in FAIL (0.06 ± 0.01 μN/μm) compared to CON (CON 0.03 ± 0.01 μN/μm) (*P b 0.05). The distance between
glass ﬁbers at resting length was not different between CON and FAIL (CON 95.0 ± 4.9 μm, FAIL 95.6 ± 2.5, P = 0.90). N = 8 CON and 13 FAIL myocytes from 3 CON and 4 FAIL hearts.
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4.1. Animal model, PAH and RV failure
The increase in end systolic pressure in MCT-treated animals is
evidence of PAH. The designation of our MCT-treated animals as heart
failure is based on the appearance of previously validated external clin-
ical signs e.g. [11–14]. The key clinical manifestations of RV failure have
been stated as exercise limitations and ﬂuid retention [20], consistent
with this, MCT-treated animals showed a depressed myocyte contrac-
tion–frequency response (that is, a decreased response to increased
demand) and increased wet lung: body weight, consistent with lung
congestion. However the enhanced ESPVR and dP/dt max values
(see Suppl. Table 1) do not support thepresence of systolic failure. Inter-
vention upon appearance of clinical signs was a condition of ethicalA
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Fig. 4.Diastolic sarcomere length and [Ca2+]i in CON and FAILmyocytes. A. Resting SL in RV (N=
hearts. Resting SL was signiﬁcantly shorter in FAIL RV cells ***P b 0.001. B. There were no differe
21 CON and 23 FAIL; LV N = 21 CON and 24 FAIL myocytes) from 3 CON and 4 FAIL hearts.approval and more likely occurs at the onset of heart failure than at
end-stage failure when in vivo systolic dysfunction may become
apparent.
4.2. Evidence for diastolic dysfunction at the level of the failing single
myocyte
Reduction of CK activity has been described in human diseasedmyo-
cardium [4,5] and has been linked to contractile dysfunction, reduction
in contractile reserve [6,21–23] and increased mortality [5]. Consistent
with these observations, we show decreased expression of the most
abundant form of CK, in hearts from PAH animals with RV failure. We
also present evidence for diastolic dysfunction in myocytes from failing
hearts. This dysfunction was ameliorated by addition of exogenous CK
and mimicked in healthy cells by pharmacological inhibition of CK.B
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Fig. 5. Estimation of myoﬁlament Ca2+ sensitivity in intact CON and FAIL myocytes. A. In intact cells (loaded with Fura-2 and in which SERCA is inhibited by thapsigargin) a near steady-
state relationship between [Ca2+]i and SL change was achieved during re-lengthening, following stimulation at 10 Hz in 5 mM Ca2+-Tyrode at 20–23 °C. Inset demonstrates the linear
relationship (r2 = 0.98) during relaxation. B. The mean slope of SL-340:380 ratio was less steep in both failing RV and LV cells compared to CON, suggesting decreased myoﬁlament
Ca2+ sensitivity in FAIL myocytes. N = 22 CON and 17 FAIL; LV, N = 15 CON and 15 FAIL myocytes from 3 CON and 3 FAIL hearts. *P b 0.05, ***P b 0.001.
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ponent of diastolic dysfunction induced by PAH.
Previous work has shown that diastolic function was preserved
in MCT-induced hypertrophy prior to failure (30 mg/kg, MCT) [24].
We observed a steeper in vivo EDPVR in failing hearts but do notA B
*
Fig. 6. Ca2+-dependent and -independent contribution to diastolic SL in CON and FAILmyocyte
hearts in 1 mM Ca2+ Tyrode solution (Tyrode), Tyrode plus BAPTA-AM (BAPTA) to buffer intr
myosin ATP-ase. There was a signiﬁcant difference in SL in Tyrode between the 2 groups (CON
and progressive increase in SL following BAPTA and then BAPTA + BDM. B. Change in dias
(BAPTA+ BDMminus BAPTA) mechanisms. There was no difference in the Ca2+-dependent ch
greater than CON and Ca2+-dependent changes in FAIL. N = 18 CON and 25 FAIL myocytes froattribute this to increased ﬁbrosis. At a similar stage of disease
other MCT studies have not observed increase in ﬁbrosis [25] while
others have [12]. When increased ﬁbrosis is present it could contrib-
ute to diastolic dysfunction by increasing stiffness and resistance to
RV ﬁlling.s. A. Repeatedmeasurement of diastolic SL in intact myocytes from the RV of CON and FAIL
acellular Ca2+, and following further addition of 40 mM BDM (BAPTA + BDM) to inhibit
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ange between the 2 groups. Ca2+-independent change in FAILmyocytes was signiﬁcantly
m 3 CON and 3 FAIL hearts, *P b 0.05, **P b 0.01, ***P b 0.001.
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myocytes is a useful approach to isolate intracellular mechanisms
from the inﬂuence of the extracellular matrix [26] and using this
approachwe sawa steeper EDFLR in failingmyocytes. Diastolic dysfunc-
tion and increased passive stiffness in the myocytes of human sufferers
of PAH have been linked to reduced phosphorylation of titin [26]. WeA
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heart failure patients [26].4.3. Creatine kinase and mechanisms determining diastolic sarcomere
length
Weobserved signiﬁcant reduction of the 2major CK isoforms (CK-M
and CK-mito) in RV FAIL hearts. Commonly described regulators of
diastolic SL are diastolic [Ca2+]i andmyoﬁlament Ca2+ sensitivity, how-
ever we saw no evidence of an increase in either of these parameters in
failingmyocytes.We do provide evidence that the reduction in diastolic
SL in failing cells occurred predominantly through a Ca2+-independent
(BDM-sensitive) rather than a Ca2+-dependent (BAPTA-sensitive)
mechanism. Importantly, we show that reduced diastolic SL was im-
proved by addition of exogenous CK in the presence of PCr, suggesting
a requirement for functional CK rather than just its physical presence,
andmimicked in healthy cells by pharmacological inhibition of CK. Reg-
ulation of SL or passive tension by increased ADP is well-documented
[27] as is an association between reduced CK activity and increased
ADP [28]. A local accumulation of ADP can occur if myoﬁbrillar CK activ-
ity is sufﬁciently impaired. As a consequence, rigor-like and slowly cy-
cling, cross-bridges can form which leads to Ca2+-independent force
production [29,30]. There is evidence that other metabolic pathways
are also compromised in this condition, for example, reduced creatine
content [24], decreased CK-mito activity, mitochondrial dysfunction
and increased glycolysis [31–33].
The steeper contraction–frequency relationship in RV FAILmyocytes
is a cellular manifestation of the inability of failing hearts to respond to
increased demand (the characteristic that underpins the NYHA classiﬁ-
cation of heart failure). The observation that inhibition of CK in CON
myocytes mimics the contraction-frequency relationship of RV FAIL
myocytes supports a central role of metabolic dysfunction in this key
characteristic of heart failure [21].
Interestingly single isoform (MCK−/−, mitochondrial CK−/− [34])
and double (CK−/− [35,36]) CK knockout mice show a mild cardiac
phenotype, demonstrating resilience to a non-functioning CK system,
some of which may be strain or sex-dependent [36] or be related to
compensatory mechanisms such as cytostructural changes to reduce
intracellular diffusion distances [37]. Creatine-deﬁciency through
knockout of the creatine transporter [38] or biosynthetic pathway
(GAMT−/− [39]) iswell tolerated,withmice able to exercise and survive
experimental myocardial infarction [40]. The GAMT−/−mice were re-
ported to have smaller hearts and lower pressures [40]. In the MCT
model the combination of reduced CK enzyme and creatine substrate
[24] in hearts that are hypertrophic, hypertensive and inﬂammatory
[41] may contribute to the differences between ﬁndings in the MCT
and KO models.4.4. Study limitations
Wedid notmeasure CK activity and there is a possiblemismatch be-
tween protein levels and activity, however in a pressure-overload
model of LV failure [42] reported similar levels in the reduction of CK-
mito protein and CK-mito activity, supportive of a link between protein
and activity levels. Our inhibitor of CKmay have off target effects such as
the modiﬁcation of sulfhydryl groups that could affect Ca2+-handling
channels such as RYR2 [43] but we do show that in permeabilized
myocytes, where [Ca2+]i is controlled, DNFB still reduced resting SL.
It is difﬁcult to directly equate our measures of SL in isolated myocytes
to those seen in vivo during a cardiac cycle. In vivo SL is still a subject
of research, but in situ SL measured in arrested mouse hearts was
found to be close to ~1.95 μm, similar to our CON SL of ~1.90 μm [44],
although the mechanical loading conditions in vivo and in isolated
myocytes is different.4.5. Conclusions
Currently, PAH treatment is focused on the pulmonary vasculature,
based on the rationale that the reversal of pulmonary hypertension
will decrease the stresses on the heart that lead to RV hypertrophy
and failure. However, at present heart failure can be treated but not
cured. Therefore the manifestation of RV dysfunction cannot be
disregarded. Novel therapies targeting both pulmonary vascular con-
striction and RV failure should be considered. Our data suggest that car-
diac energetics would be a valid potential target for therapeutic
intervention in PAH.
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